Laura Jolovic

St. Jude researchers, led by Dr. Stacey Schultz-Cherry, are asking questions about potential association between flu severity and the obesity epidemic.

Researchers identify intestinal microbiota that may predict infection risk during chemotherapy in pediatric ALL patients. Learn about the gut microbiome.

HLH, a rare disorder of the immune system, is caused by a buildup of proteins responding to infection. Read about a new treatment that limits that buildup.

Researchers learn how this housekeeper for cancer cells turns into a cancer house killer. Learn how targeting LAP could promote an anti-tumor response and slow tumor growth.

This new cancer algorithm shows possible precision options for cancer treatment.

This shape-shifting cipher of the cell may hold the key to curing cancer through causing cancer cells to kill themselves.

How close are we to another deadly influenza virus pandemic? Read about how scientists are figuring out how to prevent the next catastrophe.

Read how St. Jude is reaching out to youth for HIV education and prevention, including a clinical trial for an HIV prevention and treatment drug.

A new model explains key factors in chronic pain development, and future pain research designed to answer overlooked questions

Newly approved Vitrakvi (larotrectinib) scored high patient response rates by inhibiting a rare chromosomal abnormality that drives tumor growth.